We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

This study has been withdrawn prior to enrollment.
(Funding source was terminated before enrollment of first subject)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01312493
First Posted: March 10, 2011
Last Update Posted: August 28, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Amgen
Information provided by (Responsible Party):
UNC Lineberger Comprehensive Cancer Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)